Skip to Content

PLAQUENIL (Hydroxychloroquine Sulfate 200 mg)

Pill with imprint PLAQUENIL is White, Figure eight-shape and has been identified as Hydroxychloroquine Sulfate 200 mg. It is supplied by Sanofi-Synthelabo Inc.

Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; lyme disease, arthritis; dermatomyositis; malaria (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLAQUENIL

Hydroxychloroquine sulfate 200 mg PLAQUENIL
Hydroxychloroquine sulfate 200 mg PLAQUENIL
Hydroxychloroquine sulfate 200 mg PLAQUENIL

Hydroxychloroquine Sulfate

Imprint:
PLAQUENIL
Strength:
200 mg
Color:
White
Shape:
Figure eight-shape
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Antirheumatics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sanofi-Synthelabo Inc
National Drug Code (NDC):
00955-0790

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide